🌍·8h agodiscovery
Merck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges
Publisher
C
CNBC
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- CNBC
- Region
- Global
- Scope
- discovery
- Published
- August 4, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: CNBC
Scope: discovery
Related coverage
More related coverage
stocktitan.net/3h ago
Moderna vaccinates first participants in trial for Ebola strain with no vaccine
The Pharmaceutical Journal/4h ago
Best practice for prescribing drugs with dependence potential
Generics and Biosimilars Initiative/4h ago
Medicines for Europe calls for Biotech Act reforms to address ‘biosimilar void’
CIDRAP/4h ago